23 August 2022 - - Massachusetts, US-based pharmaceutical company Charles River Laboratories International, Inc. (NYSE: CRL) has added five Charles River Accelerator and Development Lab (CRADL) locations in California and Washington, the company said.

CRADL provides flexible, turnkey vivarium rental space supported by Charles River's technical and veterinary support expertise in key biohubs.

As part of the recent acquisition of Explora Biolabs, the company is adding two additional facilities in San Diego, to better serve the Sorrento Valley and Torrey Pines neighborhoods, and opening its first facility to serve Seattle.

Additionally, CRADL has added additional facilities in South San Francisco and a new location in Thousand Oaks.

Explora BioLabs and CRADL are spaces for clients to launch or expand their drug research programs, with the added benefit of access to Charles River's complete portfolio of integrated drug discovery and non-clinical development resources.

All locations offer rental vivarium space for both emerging and established biopharmaceutical companies and research institutions, allowing scientists to focus on research, while leaving the animal husbandry and daily vivarium management to a trusted partner.

By offering turnkey, on-demand facilities, clients are able to quickly start new projects, accelerating the early stage of research.

Explora BioLabs and CRADL operate a combined 27 vivarium facilities, providing over 370,000 square feet of turnkey rental capacity in key biohubs, including Massachusetts, California, Washington, Shanghai, and London.

This network supports the growth of the entire biotech ecosystem in each city, allowing researchers to rapidly engage in their research while maintaining the flexibility to relocate or co-locate, knowing they will have reliable, high-quality facilities nearby.

Charles River Laboratories International is an American pharmaceutical company specializing in a range of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries.